MISTY MUNGER: Open Payments
NPI 1104356393 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 51 payments from 18 companies in 2025. Trend: 2023 $1,192 · 2024 $2,726 · 2025 $1,261
Food & beverage: $1,161Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $248 |
| Actelion Pharmaceuticals US, Inc. | 5 | $211 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| United Therapeutics Corporation | 4 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Amgen Inc. | 4 | $70 |
| Merck Sharp & Dohme LLC | 2 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56 |
| Viatris Specialty LLC | 2 | $51 |
| Insmed, Inc. | 2 | $45 |
Products named: NUCALA, OPSUMIT, DUPIXENT, Tyvaso, TEZSPIRE, WINREVAIR, OFEV, YUPELRI.
Industry payments across NC — which companies pay providers there.
